Literature DB >> 21789101

Chronotherapy: a smart approach for refractory hypertension.

Salvador Pertusa1, Domingo Orozco-Beltran.   

Abstract

Patients with resistant hypertension are at greater risk for cardiovascular complications. Spreading out medication for the treatment of hypertension is a well known and widely used practice. Chronotherapy, the optimisation of schedules for administering drugs, constitutes a new option in optimising blood pressure control and reducing risk.

Entities:  

Year:  2009        PMID： 21789101      PMCID： PMC3029081          DOI： 10.1136/bcr.04.2009.1752

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  9 in total

1.  Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study.

Authors:  Takayoshi Ohkubo; Atsushi Hozawa; Junko Yamaguchi; Masahiro Kikuya; Kaori Ohmori; Mari Michimata; Mitsunobu Matsubara; Junichiro Hashimoto; Haruhisa Hoshi; Tsutomu Araki; Ichiro Tsuji; Hiroshi Satoh; Shigeru Hisamichi; Yutaka Imai
Journal:  J Hypertens       Date:  2002-11       Impact factor: 4.844

2.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

3.  Effects of time of day of treatment on ambulatory blood pressure pattern of patients with resistant hypertension.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo; José E López; Artemio Mojón; María J Fontao; Rita Soler; José R Fernández
Journal:  Hypertension       Date:  2005-08-08       Impact factor: 10.190

Review 4.  Administration-time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure.

Authors:  Ramón C Hermida; Diana E Ayala; Carlos Calvo
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-09       Impact factor: 2.894

5.  Treatment of non-dipper hypertension with bedtime administration of valsartan.

Authors:  Ramón C Hermida; Carlos Calvo; Diana E Ayala; José R Fernández; Manuel Covelo; Artemio Mojón; José E López
Journal:  J Hypertens       Date:  2005-10       Impact factor: 4.844

6.  Relationship between physical activity and blood pressure in dipper and non-dipper hypertensive patients.

Authors:  Ramón C Hermida; Carlos Calvo; Diana E Ayala; Artemio Mojón; José E López
Journal:  J Hypertens       Date:  2002-06       Impact factor: 4.844

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.

Authors:  P Verdecchia; C Porcellati; G Schillaci; C Borgioni; A Ciucci; M Battistelli; M Guerrieri; C Gatteschi; I Zampi; A Santucci; C Santucci; G Reboldi
Journal:  Hypertension       Date:  1994-12       Impact factor: 10.190

9.  Chronotherapy improves blood pressure control and reverts the nondipper pattern in patients with resistant hypertension.

Authors:  Ramón C Hermida; Diana E Ayala; José R Fernández; Carlos Calvo
Journal:  Hypertension       Date:  2007-10-29       Impact factor: 10.190
  9 in total
  1 in total

1.  Moderately increased albuminuria unmasked hypertension.

Authors:  Salvador Pertusa; Carlos Ramos-Lopez; Martha Martinez-Navas; Ana Palacios-Marqués
Journal:  BMJ Case Rep       Date:  2014-10-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.